"Quinuclidines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D011812
|
MeSH Number(s) |
D03.605.687
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Quinuclidines".
Below are MeSH descriptors whose meaning is more specific than "Quinuclidines".
This graph shows the total number of publications written about "Quinuclidines" by people in this website by year, and whether "Quinuclidines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2013 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Quinuclidines" by people in Profiles.
-
Elayapillai S, Ramraj S, Benbrook DM, Bieniasz M, Wang L, Pathuri G, Isingizwe ZR, Kennedy AL, Zhao YD, Lightfoot S, Hunsucker LA, Gunderson CC. Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer. Gynecol Oncol. 2021 01; 160(1):302-311.
-
Greenwood-Van Meerveld B, Mohammadi E, Tyler K, Pietra C, Bee LA, Dickenson A. Synergistic effect of 5-hydroxytryptamine 3 and neurokinin 1 receptor antagonism in rodent models of somatic and visceral pain. J Pharmacol Exp Ther. 2014 Oct; 351(1):146-52.
-
Choung RS, Locke GR, Francis DD, Katzka D, Winkle PJ, Orr WC, Crowell MD, Devault K, Harmsen WS, Zinsmeister AR, Talley NJ. Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placebo-controlled pharmacodynamic study. Neurogastroenterol Motil. 2014 Jan; 26(1):13-20.